Loss of Intralipid®- but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: Importance of ROS signaling

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Lou, Phing How ^a   Lucchinetti, Eliana ^a   Zhang, Liyan ^a   Affolter, Andreas ^b   Gandhi, Manoj ^a   Hersberger, Martin ^b   Warren, Blair E ^a   Lemieux, Hélène ^a   Sobhi, Hany F ^c   Clanachan, Alexander S ^a   Zaugg, Michael ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c PA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ACYLCARNITINE; CARNITINE PALMITOYLTRANSFERASE I; CYTOCHROME C OXIDASE; FRUCTOSE; INTRALIPID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N 2 MERCAPTOPROPIONYL GLYCINE; PALMITOYLCARNITINE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SEVOFLURANE; TIOPRONIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3; CARDIOTONIC AGENT; EMULSION; ETHER DERIVATIVE; ION CHANNEL; LIPID EMULSION; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3; PHOSPHOLIPID; SOYBEAN OIL; SOYBEAN OIL, PHOSPHOLIPID EMULSION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; MALE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; REPERFUSION INJURY; RESPIROMETRY; SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; DRUG EFFECTS; EMULSION; HEART; METABOLISM; MYOCARDIAL REPERFUSION INJURY; SPRAGUE DAWLEY RAT; THERAPEUTIC USE;

ANIMALS; CARDIOTONIC AGENTS; DIABETES MELLITUS, TYPE 2; ELECTRON TRANSPORT COMPLEX IV; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FRUCTOSE; HEART; ION CHANNELS; MALE; METHYL ETHERS; MITOCHONDRIAL PROTEINS; MYOCARDIAL REPERFUSION INJURY; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SOYBEAN OIL;

EID: 84939158397     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104971     Document Type: Article

References (55)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: 948-954.
2. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44 Suppl 2: S14-21. (Pubitemid 32844108)
3. Abbott RD, Donahue RP, Kannel WB, Wilson PW (1988) The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA 260: 3456-3460. (Pubitemid 19003125)
4. Herlitz J, Wognsen GB, Emanuelsson H, Haglid M, Karlson BW, et al. (1996) Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 19: 698-703. (Pubitemid 126752470)
5. Gonsolin D, Couturier K, Garait B, Rondel S, Novel-Chate V, et al. (2007) High dietary sucrose triggers hyperinsulinemia, increases myocardial beta-oxidation, reduces glycolytic flux and delays post-ischemic contractile recovery. Mol Cell Biochem 295: 217-228. (Pubitemid 46158004)
6. Harmancey R, Vasquez HG, Guthrie PH, Taegtmeyer H (2013) Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart. FASEB J 27: 3966-3978.
7. Huisamen B (2003) Protein kinase B in the diabetic heart. Mol Cell Biochem 249: 31-38.
8. Morel S, Berthonneche C, Tanguy S, Toufektsian MC, Foulon T, et al. (2003) Insulin resistance modifies plasma fatty acid distribution and decreases cardiac tolerance to in vivo ischaemia/reperfusion in rats. Clin Exp Pharmacol Physiol 30: 446-451. (Pubitemid 36836559)
9. Rahman S, Li J, Bopassa JC, Umar S, Iorga A, et al. (2012) Phosphorylation of GSK-3beta mediates intralipid-induced cardioprotection against ischemia/reperfusion injury. Anesthesiology 115: 242-253.
10. Li J, Iorga A, Sharma S, Youn JY, Partow-Navid R, et al. (2012) Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A. Anesthesiology 117: 836-846.
11. Lou PH, Lucchinetti E, Zhang L, Affolter A, Schaub MC, et al. (2014) The mechanism of IntralipidH-mediated cardioprotection: complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases. PLoS One 9: e87205.
12. Tanaka K, Kehl F, Gu W, Krolikowski JG, Pagel PS, et al. (2002) Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 282: H2018-2023. (Pubitemid 34663008)
13. Lemoine S, Durand C, Zhu L, Ivasceau C, Lepage O, et al. (2010) Desflurane-induced postconditioning of diabetic human right atrial myocardium in vitro. Diabetes Metab 36: 21-28.
14. Muravyeva M, Baotic I, Bienengraeber M, Lazar J, Bosnjak ZJ, et al. (2014) Cardioprotection during Diabetes: The Role of Mitochondrial DNA. Anesthesiology 120: 870-879.
15. Dai S, McNeill JH (1995) Fructose-induced hypertension in rats is concentration-and duration-dependent. J Pharmacol Toxicol Methods 33: 101-107.
16. Samuel VT (2011) Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab 22: 60-65.
17. Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP (2008) Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 295: E1269-1276.
18. Lou PH, Zhang L, Lucchinetti E, Heck M, Affolter A, et al. (2013) Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury. Cardiovasc Res 97: 251-261.
19. Zaugg M, Wang L, Zhang L, Lou PH, Lucchinetti E, et al. (2012) Choice of anesthetic combination determines Ca2+ leak after ischemia-reperfusion injury in the working rat heart: favorable versus adverse combinations. Anesthesiology 116: 648-657.
20. Gardner PR (2002) Aconitase: sensitive target and measure of superoxide. Methods Enzymol 349: 9-23.
21. Srere PA (1969) Citrate synthase. Methods Enzymol 13: 3-11.
22. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP (1997) A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253: 162-168. (Pubitemid 27508167)
23. Franks NP, Lieb WR (1996) Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments. Anesthesiology 84: 716-720. (Pubitemid 26092542)
24. Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, et al. (2010) Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology 113: 541-551.
25. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, et al. (2005) Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112: 2686-2695. (Pubitemid 41532606)
26. Motulsky H, Christopoulos A (2004) Fitting models to biological data using linear and non-linear regression: a practical guide to curve fitting. New York: Oxford University Press, Inc. 352 p.
27. Hulver MW, Berggren JR, Carper MJ, Miyazaki M, Ntambi JM, et al. (2005) Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab 2: 251-261.
28. Sedlic F, Pravdic D, Ljubkovic M, Marinovic J, Stadnicka A, et al. (2009) Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth Analg 109: 405-411.
29. Hanley PJ, Ray J, Brandt U, Daut J (2002) Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 544: 687-693. (Pubitemid 35355950)
30. Hirata N, Shim YH, Pravdic D, Lohr NL, Pratt PF Jr, et al. (2011) Isoflurane differentially modulates mitochondrial reactive oxygen species production via forward versus reverse electron transport flow: implications for preconditioning. Anesthesiology 115: 531-540.
31. Agarwal B, Dash RK, Stowe DF, Bosnjak ZJ, Camara AK (2014) Isoflurane modulates cardiac mitochondrial bioenergetics by selectively attenuating respiratory complexes. Biochim Biophys Acta 1837: 354-365.
32. Srinivasan S, Avadhani NG (2012) Cytochrome c oxidase dysfunction in oxidative stress. Free Radic Biol Med 53: 1252-1263.
33. Burwell LS, Nadtochiy SM, Brookes PS (2009) Cardioprotection by metabolic shut-down and gradual wake-up. J Mol Cell Cardiol 46: 804-810.
34. Tsutsumi YM, Yokoyama T, Horikawa Y, Roth DM, Patel HH (2007) Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci 81: 1223-1227. (Pubitemid 47513165)
35. Saotome M, Katoh H, Yaguchi Y, Tanaka T, Urushida T, et al. (2009) Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Am J - Physiol Heart Circ Physiol 296: H1125-1132.
36. Sharpe M, Perin I, Tattrie B, Nicholls P (1997) Ligation, inhibition, and activation of cytochrome c oxidase by fatty acids. Biochem Cell Biol 75: 71-79. (Pubitemid 127733130)
37. Stewart JM, Blakely JA, Johnson MD (2000) The interaction of ferrocytochrome c with long-chain fatty acids and their CoA and carnitine esters. Biochem Cell Biol 78: 675-681. (Pubitemid 32102354)
38. Hiser C, Buhrow L, Liu J, Kuhn L, Ferguson-Miller S (2013) A conserved amphipathic ligand binding region influences k-path-dependent activity of cytochrome C oxidase. Biochemistry 52: 1385-1396.
39. Cline GW, Vidal-Puig AJ, Dufour S, Cadman KS, Lowell BB, et al. (2001) In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem 276: 20240-20244.
40. Toime LJ, Brand MD (2010) Uncoupling protein-3 lowers reactive oxygen species production in isolated mitochondria. Free Radic Biol Med 49: 606-611.
41. Echtay KS, Roussel D, St-Pierre J, Jekabsons MB, Cadenas S, et al. (2002) Superoxide activates mitochondrial uncoupling proteins. Nature 415: 96-99. (Pubitemid 34062457)
42. Murphy MP, Echtay KS, Blaikie FH, Asin-Cayuela J, Cocheme HM, et al. (2003) Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria- targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J Biol Chem 278: 48534-48545. (Pubitemid 41079491)
43. Winkler E, Klingenberg M (1994) Effect of fatty acids on H+ transport activity of the reconstituted uncoupling protein. J Biol Chem 269: 2508-2515. (Pubitemid 24235743)
44. Malingriaux EA, Rupprecht A, Gille L, Jovanovic O, Jezek P, et al. (2013) Fatty Acids are Key in 4-Hydroxy-2-Nonenal-Mediated Activation of Uncoupling Proteins 1 and 2. PLoS One 8: e77786.
45. Makino A, Suarez J, Gawlowski T, Han W, Wang H, et al. (2011) Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes. Am J Physiol Regul Integr Comp Physiol 300: R1296-1302.
46. Fukuda R, Zhang H, Kim JW, Shimoda L, Dang CV, et al. (2007) HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129: 111-122. (Pubitemid 46507584)
47. Huttemann M, Lee I, Liu J, Grossman LI (2007) Transcription of mammalian cytochrome c oxidase subunit IV-2 is controlled by a novel conserved oxygen responsive element. FEBS J 274: 5737-5748. (Pubitemid 47622084)
48. Kadenbach B, Huttemann M, Arnold S, Lee I, Bender E (2000) Mitochondrial energy metabolism is regulated via nuclear-coded subunits of cytochrome c oxidase. Free Radic Biol Med 29: 211-221.
49. Bourens M, Fontanesi F, Soto IC, Liu J, Barrientos A (2013) Redox and reactive oxygen species regulation of mitochondrial cytochrome C oxidase biogenesis. Antioxid Redox Signal 19: 1940-1952.
50. Liu J, Barrientos A (2013) Transcriptional Regulation of Yeast Oxidative Phosphorylation Hypoxic Genes by Oxidative Stress. Antioxid Redox Signal 19: 1916-1927.
51. Kevin LG, Novalija E, Riess ML, Camara AK, Rhodes SS, et al. (2003) Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 96: 949-955, table of contents. (Pubitemid 36359021)
52. Mullenheim J, Ebel D, Frassdorf J, Preckel B, Thamer V, et al. (2002) Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 96: 934-940. (Pubitemid 34266688)
53. Huhn R, Heinen A, Hollmann MW, Schlack W, Preckel B, et al. (2010) Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo. Nutr Metab Cardiovasc Dis 20: 706-712.
54. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, et al. (2004) Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 101: 299-310. (Pubitemid 38988484)
55. Deyhimy DI, Fleming NW, Brodkin IG, Liu H (2007) Anesthetic preconditioning combined with postconditioning offers no additional benefit over preconditioning or postconditioning alone. Anesth Analg 105: 316-324. (Pubitemid 47196404)